斯塔林肿瘤
STLN
6.43
-0.48
-6.95%
斯塔林肿瘤
US · STLN
#3565 按市值排名
6.43
-0.48
-6.95%
实时 - 追踪5344个代码 - 心跳于481秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
增持
- 最近一期（2026/Q3）披露持股的机构数量增加了1家。
- 机构持股总比例上升了0.5个百分点。
机构持股
- 机构持股比例
- 48.09% +0.48pp
- 机构数量
- 149 +1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund23.21%
Hedge Fund14.72%
Individual/Insider12.78%
VC/PE Fund3.58%
Family Office/Trust2.49%
Public Company1.49%
Private Company1.30%
Insurance Company1.19%
Other39.17%
主要股东 截至 2026-08-14
Jorey Chernett
10.46% · 10.66M 股
BlackRock
4.66% · 4.75M 股
Vanguard Capital Management, LLC
3.70% · 3.77M 股
M33 Growth, LLC
3.58% · 3.64M 股
Parian Global Management LP
3.49% · 3.55M 股
Deerfield Management Company, L.P.
3.30% · 3.36M 股
Josh Arnold Investment Consultant, LLC
2.42% · 2.46M 股
Geode Capital Management, LLC
1.86% · 1.90M 股
Wexford Capital LP
1.68% · 1.71M 股
State Street Global Advisors
1.52% · 1.55M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 32次买入 · 18次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Jorey Chernett | -- | 10.46% |
| Daniel Virnich | Chief Executive Officer | 0.70% |
| Bradford Hively | Vice Chairperson | 0.31% |
| Anne McGeorge | Independent Director | 0.29% |
| Karen Marie Johnson | Independent Director | 0.28% |
| Mark Pacala | Independent Director | 0.25% |
| Mohit Kaushal | Independent Director | 0.17% |
| Kristin England | Chief Administrative Officer | 0.10% |
| Jeffrey Langsam | -- | 0.06% |
| Robert Carter | Officer | 0.05% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-08-20 | Bradford Hively | Vice Chairperson | Open Market Disposition | -298,853 | $6.51 |
| 2026-08-13 | Jorey Chernett | -- | Open Market Acquisition | +12,000 | $6.54 |
| 2026-08-12 | Jorey Chernett | -- | Open Market Derivative Dispositi | -100 | $9.00 |
| 2026-07-26 | Mark Pacala | Independent Director | Other Acquisition | +30,120 | -- |
| 2026-07-26 | Mark Stolper | Director | Other Acquisition | +31,124 | -- |
| 2026-07-26 | Bradford Hively | Vice Chairperson | Other Acquisition | +27,108 | -- |
| 2026-07-26 | Anne McGeorge | Independent Director | Other Acquisition | +41,165 | -- |
| 2026-07-26 | Mohit Kaushal | Independent Director | Other Acquisition | +33,133 | -- |
| 2026-07-26 | Kimberly Commins-Tzoumakas | Director | Other Acquisition | +29,116 | -- |
| 2026-07-26 | Karen Marie Johnson | Independent Director | Other Acquisition | +31,124 | -- |
| 2026-07-20 | Jorey Chernett | -- | Open Market Acquisition | +18,000 | $5.27 |
| 2026-07-13 | Yale Podnos | Chief Medical Officer & President of Practice | Derivative Exercise and Sale | -23,452 | $1.87–6.43 |
| 2026-07-09 | Jorey Chernett | -- | Open Market Acquisition | +15,000 | $5.85 |
| 2026-07-06 | Mark Stolper | Director | Other Acquisition | +25,833 | -- |
| 2026-07-06 | Kimberly Commins-Tzoumakas | Director | Other Acquisition | +17,185 | -- |
| 2026-06-22 | Jorey Chernett | -- | Open Market Acquisition | +18,000 | $5.02 |
| 2026-06-07 | Yale Podnos | Chief Medical Officer & President of Practice | Automatic Disposition | -23,451 | $5.38 |
| 2026-06-03 | Jorey Chernett | -- | Open Market Acquisition | +12,000 | $4.75 |
| 2026-05-20 | Daniel Virnich | Chief Executive Officer | Other Disposition | -23,058 | $4.47 |
| 2026-05-20 | Yale Podnos | Chief Medical Officer & President of Practice | Other Disposition | -1,805 | $4.47 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:10 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
斯塔林肿瘤 讨论区 0 条评论